Armentrout Erin I, Liu George Y, Martins Gislâine A
Lung Institute, Cedars-Sinai Medical Center (CSMC), Los Angeles, CA 90048, USA.
Division of Pulmonary and Critical Care Medicine, CSMC, Los Angeles, CA 90048, USA.
Microorganisms. 2020 Dec 6;8(12):1936. doi: 10.3390/microorganisms8121936.
is a wide-spread human pathogen, and one of the top causative agents of nosocomial infections. The prevalence of antibiotic-resistant strains, which are associated with higher mortality and morbidity rates than antibiotic-susceptible strains, is increasing around the world. Vaccination would be an effective preventive measure against infection, but to date, every vaccine developed has failed in clinical trials, despite inducing robust antibody responses. These results suggest that induction of humoral immunity does not suffice to confer protection against the infection. Evidence from studies in murine models and in patients with immune defects support a role of T cell-mediated immunity in protective responses against . Here, we review the current understanding of the mechanisms underlying adaptive immunity to infections and discuss these findings in light of the recent vaccine trial failures. We make the case for the need to develop anti- vaccines that can specifically elicit robust and durable protective memory T cell subsets.
是一种广泛传播的人类病原体,也是医院感染的主要致病因素之一。与抗生素敏感菌株相比,抗生素耐药菌株导致更高的死亡率和发病率,其在全球的 prevalence 正在上升。接种疫苗将是预防感染的有效措施,但迄今为止,尽管诱导了强烈的抗体反应,但开发的每种疫苗在临床试验中均告失败。这些结果表明,诱导体液免疫不足以提供针对感染的保护。来自小鼠模型研究和免疫缺陷患者的证据支持 T 细胞介导的免疫在针对感染的保护性反应中的作用。在这里,我们回顾了目前对感染适应性免疫潜在机制的理解,并根据最近的疫苗试验失败情况讨论了这些发现。我们提出有必要开发能够特异性引发强大且持久的保护性记忆 T 细胞亚群的抗疫苗。 (注:原文中“prevalence”未翻译,可能是有拼写错误或不完整表述,这里暂保留英文)